Pertuzumab and Trastuzumab: The Rationale Way to Synergy

Anais da Academia Brasileira de Ciencias - Brazil
doi 10.1590/0001-3765201620150178
Full Text
Abstract

Available in full text

Date
Authors
Publisher

FapUNIFESP (SciELO)

Related search

Synergy Between Trastuzumab and Pertuzumab for Human Epidermal Growth Factor 2 (Her2) From Colocalization: An in Silicobased Mechanism

Breast Cancer Research
Cancer ResearchOncology
2011English

Skin/Nail Infections With the Addition of Pertuzumab to Trastuzumab-Based Chemotherapy

Breast Cancer Research and Treatment
Cancer ResearchOncology
2014English

Corrrection: Article on Cardiac Toxicity and Trastuzumab Combined With Pertuzumab

Clinical Cancer Research
Cancer ResearchOncology
2008English

Correction: Cryo-Em Structure of HER2-trastuzumab-pertuzumab Complex

PLoS ONE
Multidisciplinary
2019English

Patient With Metastatic Breast Cancer, HER2-positive, Trastuzumab- And Pertuzumab-Resistant Responding to Lapatinib

AboutOpen
2018English

Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2019English

Tumor Infiltrating Lymphocytes in Patients Receiving Trastuzumab/Pertuzumab-Based Chemotherapy: A TRYPHAENA Substudy

European Journal of Cancer
Cancer ResearchOncology
2018English

Pcn74 - A Budget-Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early Her2-Positive Breast Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Development of a Subcutaneous Fixed-Dose Combination of Pertuzumab and Trastuzumab: Results From the Phase Ib Dose-Finding Study

Journal of Clinical Pharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy